Leading independent law firm Johnson Winter & Slattery has advised Moderna, a pioneer in mRNA vaccines, on its 10-year strategic deal with the Commonwealth Government to produce mRNA vaccines in Australia.
The strategic partnership deal will see Moderna establish a state-of-the-art, mRNA vaccine manufacturing facility in Victoria capable of producing up to 100 million mRNA vaccines a year. Construction is due to begin by the end of this year.
The Australian facility will give Australia access to large volumes of vaccines produced domestically (currently planned to include COVID-19, influenza, and respiratory syncytial virus vaccines). The facility will also be a key resource in supporting the development and production of vaccines for a future pandemic. As part of the strategic partnership, Moderna also expects to support Australia's mRNA research, development, and industry ecosystem, including engagement with collaborative research partnerships with Australian institutions and establishing a Regional Research Centre for respiratory medicines and tropical diseases.
Johnson Winter & Slattery worked with Moderna’s US lawyers, Goodwin Procter LLP. The Johnson Winter & Slattery team was led by partner Christine Ecob, supported by partner Avendra Singh and special counsel Ken Chan. The team also included partners Craig Wappett, Andy Milidoni, William Oxby, and associates Chiara D’Ercole and Varshini Rajendran.
Christine Ecob congratulated Moderna on signing its first onshore manufacturing agreement of this nature, and said:
“This deal will enable Australia to join Moderna’s global research and resilience program that will put us at the forefront of research and development of mRNA vaccines globally and provide a strong base for fighting any new global pandemic. We are delighted to have supported Moderna in this important deal for Australia.”
About Johnson Winter & Slattery
Johnson Winter & Slattery is an independent national Australian law firm with over 70 partners and offices across Australia. We advise major Australian and international corporations and investment funds on their most challenging transactions and disputes across Australia and surrounding regions. Working closely with clients, knowing their business, and appreciating their objectives, we tailor our approach to deliver optimal commercial outcomes.
Media contacts:
Daya Knapton, Communications Manager
E: Daya.Knapton@jws.com.au
T: +61 2 8247 9638
Kate Potter, Business Development Director
E: Kate.Potter@jws.com.au
T: +61 2 8247 9659